Siste oppdatering :
19/11/2024
Forskerteamet - Novartis, Menges, Slovenia   pdf  
Slovenia
farmasøytiske laboratorier
Novartis, Menges, Slovenia
Menges
Referanser   Referanser   (2)  
1
Study of the Stability of Sandoz Rituximab Biosimilar Rixathon®/Riximyo® When Subjected for up to 21 Days to Ambient Storage.
Borišek R, Mischo A, Šmid I. (roman.borisek@novartis.com)
Drugs R D - 2022 - ; 22,3: 225–234
2
Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion.
Vimpolsek M, Gottar-Guillier M, Rossy E. (maja.vimpolsek@novartis.com)
Drugs R D - 2019 - 19: 127–140.

Lister   molekyler Studerte   (2)  
Immunosuppressiva Injeksjon Infliximab
kreft narkotika Injeksjon Rituximab

  Mentions Légales